Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ligand Pharm
(NQ:
LGND
)
105.80
-0.06 (-0.06%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
113,893
Open
106.00
Bid (Size)
105.57 (14)
Ask (Size)
106.06 (5)
Prev. Close
105.86
Today's Range
102.60 - 106.16
52wk Range
49.24 - 112.12
Shares Outstanding
16,676,532
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
August 20, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Looking Into Ligand Pharmaceuticals's Recent Short Interest
August 16, 2024
Via
Benzinga
Performance
YTD
+46.31%
+46.31%
1 Month
+1.44%
+1.44%
3 Month
+20.35%
+20.35%
6 Month
+38.70%
+38.70%
1 Year
+59.00%
+59.00%
More News
Read More
Stock Market Rally Begins After Global Rout; Palantir, Eli Lilly, Fortinet Jump: Weekly Review
August 09, 2024
Via
Investor's Business Daily
LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 06, 2024
Via
InvestorPlace
Assessing Ligand Pharmaceuticals: Insights From 6 Financial Analysts
July 30, 2024
Via
Benzinga
What 4 Analyst Ratings Have To Say About Ligand Pharmaceuticals
June 28, 2024
Via
Benzinga
Halozyme And Ligand — Two Leading Biotechs — Smash Quarterly Forecasts
August 06, 2024
Via
Investor's Business Daily
Ligand Reports Second Quarter 2024 Financial Results
August 06, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
July 23, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
5 Best Short-Term Stocks to Consider Investing In
July 10, 2024
Via
MarketBeat
Ligand to Acquire APEIRON Biologics AG for $100 Million
July 08, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Lifecore Biomedical Announces Cooperation Agreement with 22NW
July 01, 2024
From
Lifecore Biomedical, Inc.
Via
GlobeNewswire
Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
June 27, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
June 18, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand to Participate in Upcoming Investor Conferences
May 23, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
3 Magnificent Growth Stocks to Buy Hand Over Fist
May 22, 2024
Via
The Motley Fool
Topics
Economy
Exposures
Interest Rates
3 Must-Buy Biotech Stocks Before the Summer Rally Kicks Off
May 20, 2024
Via
InvestorPlace
LGND Stock Earnings: Ligand Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Ligand Reports First Quarter 2024 Financial Results
May 07, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement
May 07, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Don't Overlook These Top Medical Stocks As Q1 Earnings Approach
May 07, 2024
Via
Talk Markets
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
April 23, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
7 Small-Cap Stocks for the Thinking Speculator
April 08, 2024
Via
InvestorPlace
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
April 08, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
April 03, 2024
From
Ligand Pharmaceuticals Incorporated
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.